Asia Pacific Aquatic Veterinary Market Size and Forecast (2021

Description

List of Tables

The Asia Pacific Aquatic Veterinary Market is projected to grow significantly, reaching an estimated US$ 424.3 million by 2031, up from US$ 312.2 million in 2024. This growth represents a compound annual growth rate (CAGR) of 4.5% from 2025 to 2031.

Executive Summary and Market Analysis

The Asia Pacific region, which includes major countries such as China, India, Japan, and Australia, is experiencing rapid growth in its aquatic veterinary market. The primary driver of this growth is the aquaculture industry, which is the largest producer of farmed fish and seafood globally. Governments in the region are increasingly recognizing the economic importance of aquaculture and its role in ensuring food security for their populations. As a result, they are implementing supportive legislation aimed at enhancing the health of aquatic species and improving aquaculture practices. This includes funding for research and development, as well as initiatives to raise awareness about biosecurity and disease control in aquaculture.

In addition to government support, companies in the aquatic veterinary sector are actively introducing new products, expanding into new markets, and forming strategic partnerships to strengthen their market positions. The combined efforts of both governmental and business entities create a favorable environment for the growth of aquatic veterinary services in the Asia Pacific region.

Strategic Insights

Market Segmentation Analysis

The Asia Pacific Aquatic Veterinary Market can be segmented in several ways:

By Type: The market is divided into Diagnostic and Treatment segments, with the Treatment segment leading in 2024.
By Diagnostic Type: This includes Serological, Molecular Diagnosis, DNA Sequencing, and other diagnostics, with Molecular Diagnosis being the dominant segment in 2024.
By Treatment Type: The market is segmented into Vaccines, Medications, and Supplements, where Medications held the largest share in 2024.
By Species: The market includes Fish, Crustaceans, Mollusca, and others, with Fish being the leading segment.
By Disease Source: This includes Bacterial, Viral, Parasites, and others, with Bacterial diseases dominating the market.
By Route of Administration: The market is segmented into Water Medication, Medicated Feed, and other routes, with Water Medication being the most prevalent method in 2024.

Market Outlook

The increasing regulatory and consumer emphasis on sustainable aquaculture presents significant opportunities for aquatic veterinarians. They can play crucial roles as consultants and policymakers, influencing health and welfare standards in the industry. Initiatives such as the FAO Guidelines for Sustainable Aquaculture promote practices like recirculating aquaculture systems (RAS) and integrated multi-trophic aquaculture (IMTA), which necessitate health protocols that veterinarians are qualified to design and certify.

These guidelines underscore the importance of veterinary expertise in developing health programs that comply with regulations and in certifying farms for eco-labels such as the Aquaculture Stewardship Council (ASC) and Marine Stewardship Council (MSC). Veterinarians can leverage their knowledge to advise on biosecurity measures, disease-resistant breeding, and welfare protocols, thereby enhancing diagnostic infrastructure and supporting sustainable production for export markets.

The World Veterinary Association's 2024 factsheet on farmed fish welfare highlights the need for veterinarians to lead in establishing standards that minimize antibiotic use and improve transport conditions for aquatic species. This initiative is bolstered by collaborations with the World Aquatic Veterinary Medical Association (WAVMA) for global policy advocacy.

Country Insights

The Asia Pacific Aquatic Veterinary Market is further segmented by country, including China, Japan, India, Australia, South Korea, and the Rest of APAC. China is the largest market player, holding a significant share in 2024.

According to a report by the World Aquaculture Society published in December 2024, China's aquaculture production reached 58.10 million tons, accounting for 81.6% of the country's total aquatic product output and approximately 60% of global aquaculture production in 2023. China has established itself as a leading global aquaculture producer, with over 300 aquatic species farmed and a per capita annual consumption of aquatic products reaching 41.2 kg, more than double the world average. Notably, around 25% of the animal protein consumed in China comes from farmed aquatic products.

Chinese aquaculture businesses are increasingly focused on expanding their operations. For instance, in November 2023, Merck Animal Health launched two training modules in its Fish Welfare series to empower aquaculture businesses with best practices for maintaining fish health, aligning with government efforts to standardize veterinary care.

Additionally, Nordic Aqua Partners A/S, a Norwegian company, began constructing China's first land-based salmon farm in December 2020, aiming to produce approximately 36,000 metric tons of salmon annually. The growing seafood consumption in China, coupled with rising aquaculture activities, is driving increased seafood production. However, projections indicate that China may face challenges related to overconsumption of seafood by 2030.

Company Profiles

Key players in the Asia Pacific Aquatic Veterinary Market include Thermo Fisher Scientific Inc., Merck KGaA, Zoetis Inc., Virbac SA, Phibro Animal Health Corp, HIPRA SA, Indian Immunologicals Ltd., Esox Biologics Ltd., Ceva Polchem Pvt Ltd., and Aquatic Diagnostics Ltd. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative products to consumers.

Product Code: TIPRE00042715

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macroeconomic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country-level data:

4. Aquatic Veterinary Market Landscape

4.1 Market Overview
4.2 PEST Analysis

5. Asia Pacific Aquatic Veterinary Market - Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:

6. Aquatic Veterinary Market - Asia Pacific Market Analysis

6.1 Asia Pacific Aquatic Veterinary Market Revenue (US$ Million), 2024 - 2031
6.2 Asia Pacific Aquatic Veterinary Market Forecast and Analysis

7. Asia Pacific Aquatic Veterinary Market Revenue Analysis - by Type

7.1 Diagnostic
- 7.1.1 Overview
- 7.1.2 Diagnostic: Asia Pacific Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 Treatment
- 7.2.1 Overview
- 7.2.2 Treatment: Asia Pacific Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

8. Asia Pacific Aquatic Veterinary Market Revenue Analysis - by Diagnostic Type

8.1 Serological
- 8.1.1 Overview
- 8.1.2 Serological: Asia Pacific Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 Molecular Diagnosis
- 8.2.1 Overview
- 8.2.2 Molecular Diagnosis: Asia Pacific Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 DNA Sequencing
- 8.3.1 Overview
- 8.3.2 DNA Sequencing: Asia Pacific Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Other Diagnostics
- 8.4.1 Overview
- 8.4.2 Other Diagnostics: Asia Pacific Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

9. Asia Pacific Aquatic Veterinary Market Revenue Analysis - by Treatment Type

9.1 Vaccines
- 9.1.1 Overview
- 9.1.2 Vaccines: Asia Pacific Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Medications
- 9.2.1 Overview
- 9.2.2 Medications: Asia Pacific Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.3 Supplements
- 9.3.1 Overview
- 9.3.2 Supplements: Asia Pacific Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

10. Asia Pacific Aquatic Veterinary Market Revenue Analysis - by Species

10.1 Fish
- 10.1.1 Overview
- 10.1.2 Fish: Asia Pacific Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 Crustaceans
- 10.2.1 Overview
- 10.2.2 Crustaceans: Asia Pacific Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Mollusca
- 10.3.1 Overview
- 10.3.2 Mollusca: Asia Pacific Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4 Others
- 10.4.1 Overview
- 10.4.2 Others: Asia Pacific Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

11. Asia Pacific Aquatic Veterinary Market Revenue Analysis - by Diseases Source

11.1 Bacterial
- 11.1.1 Overview
- 11.1.2 Bacterial: Asia Pacific Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Viral
- 11.2.1 Overview
- 11.2.2 Viral: Asia Pacific Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.3 Parasites
- 11.3.1 Overview
- 11.3.2 Parasites: Asia Pacific Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.4 Others
- 11.4.1 Overview
- 11.4.2 Others: Asia Pacific Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

12. Asia Pacific Aquatic Veterinary Market Revenue Analysis - by Route Of Administration

12.1 Water Medication
- 12.1.1 Overview
- 12.1.2 Water Medication: Asia Pacific Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Medicated Feed
- 12.2.1 Overview
- 12.2.2 Medicated Feed: Asia Pacific Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Other Route of Administrations
- 12.3.1 Overview
- 12.3.2 Other Route of Administrations: Asia Pacific Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

13. Asia Pacific Aquatic Veterinary Market - Country Analysis

13.1 Asia Pacific
- 13.1.1 Asia Pacific Aquatic Veterinary Market Revenue and Forecast and Analysis - by Country
  - 13.1.1.1 Asia Pacific Aquatic Veterinary Market Revenue and Forecast and Analysis - by Country
  - 13.1.2.2 China: Asia Pacific Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 13.1.2.2.1 China: Asia Pacific Aquatic Veterinary Market Share - by Type
    - 13.1.2.2.2 China: Asia Pacific Aquatic Veterinary Market Share - by Diagnostic Type
    - 13.1.2.2.3 China: Asia Pacific Aquatic Veterinary Market Share - by Treatment Type
    - 13.1.2.2.4 China: Asia Pacific Aquatic Veterinary Market Share - by Species
    - 13.1.2.2.5 China: Asia Pacific Aquatic Veterinary Market Share - by Diseases Source
    - 13.1.2.2.6 China: Asia Pacific Aquatic Veterinary Market Share - by Route Of Administration
  - 13.2.3.3 Japan: Asia Pacific Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 13.2.3.3.1 Japan: Asia Pacific Aquatic Veterinary Market Share - by Type
    - 13.2.3.3.2 Japan: Asia Pacific Aquatic Veterinary Market Share - by Diagnostic Type
    - 13.2.3.3.3 Japan: Asia Pacific Aquatic Veterinary Market Share - by Treatment Type
    - 13.2.3.3.4 Japan: Asia Pacific Aquatic Veterinary Market Share - by Species
    - 13.2.3.3.5 Japan: Asia Pacific Aquatic Veterinary Market Share - by Diseases Source
    - 13.2.3.3.6 Japan: Asia Pacific Aquatic Veterinary Market Share - by Route Of Administration
  - 13.3.4.4 India: Asia Pacific Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 13.3.4.4.1 India: Asia Pacific Aquatic Veterinary Market Share - by Type
    - 13.3.4.4.2 India: Asia Pacific Aquatic Veterinary Market Share - by Diagnostic Type
    - 13.3.4.4.3 India: Asia Pacific Aquatic Veterinary Market Share - by Treatment Type
    - 13.3.4.4.4 India: Asia Pacific Aquatic Veterinary Market Share - by Species
    - 13.3.4.4.5 India: Asia Pacific Aquatic Veterinary Market Share - by Diseases Source
    - 13.3.4.4.6 India: Asia Pacific Aquatic Veterinary Market Share - by Route Of Administration
  - 13.4.5.5 Australia: Asia Pacific Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 13.4.5.5.1 Australia: Asia Pacific Aquatic Veterinary Market Share - by Type
    - 13.4.5.5.2 Australia: Asia Pacific Aquatic Veterinary Market Share - by Diagnostic Type
    - 13.4.5.5.3 Australia: Asia Pacific Aquatic Veterinary Market Share - by Treatment Type
    - 13.4.5.5.4 Australia: Asia Pacific Aquatic Veterinary Market Share - by Species
    - 13.4.5.5.5 Australia: Asia Pacific Aquatic Veterinary Market Share - by Diseases Source
    - 13.4.5.5.6 Australia: Asia Pacific Aquatic Veterinary Market Share - by Route Of Administration
  - 13.5.6.6 South Korea: Asia Pacific Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 13.5.6.6.1 South Korea: Asia Pacific Aquatic Veterinary Market Share - by Type
    - 13.5.6.6.2 South Korea: Asia Pacific Aquatic Veterinary Market Share - by Diagnostic Type
    - 13.5.6.6.3 South Korea: Asia Pacific Aquatic Veterinary Market Share - by Treatment Type
    - 13.5.6.6.4 South Korea: Asia Pacific Aquatic Veterinary Market Share - by Species
    - 13.5.6.6.5 South Korea: Asia Pacific Aquatic Veterinary Market Share - by Diseases Source
    - 13.5.6.6.6 South Korea: Asia Pacific Aquatic Veterinary Market Share - by Route Of Administration
  - 13.6.7.7 Rest of APAC: Asia Pacific Aquatic Veterinary Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
    - 13.6.7.7.1 Rest of APAC: Asia Pacific Aquatic Veterinary Market Share - by Type
    - 13.6.7.7.2 Rest of APAC: Asia Pacific Aquatic Veterinary Market Share - by Diagnostic Type
    - 13.6.7.7.3 Rest of APAC: Asia Pacific Aquatic Veterinary Market Share - by Treatment Type
    - 13.6.7.7.4 Rest of APAC: Asia Pacific Aquatic Veterinary Market Share - by Species
    - 13.6.7.7.5 Rest of APAC: Asia Pacific Aquatic Veterinary Market Share - by Diseases Source
    - 13.6.7.7.6 Rest of APAC: Asia Pacific Aquatic Veterinary Market Share - by Route Of Administration

14 Competitive Landscape

14.1 Heat Map Analysis by Key Players
14.2 Company Positioning & Concentration

15 Industry Landscape

15.1 Overview
15.2 New Product Development
15.3 Merger and Acquisition
15.4 Other Strategic Developments

16 COMPANY PROFILES

16.1 Thermo Fisher Scientific Inc
- 16.1.1 Key Facts
- 16.1.2 Business Description
- 16.1.3 Products and Services
- 16.1.4 Financial Overview
- 16.1.5 SWOT Analysis
- 16.1.6 Key Developments
16.2 Merck KGaA
- 16.2.1 Key Facts
- 16.2.2 Business Description
- 16.2.3 Products and Services
- 16.2.4 Financial Overview
- 16.2.5 SWOT Analysis
- 16.2.6 Key Developments
16.3 Zoetis Inc
- 16.3.1 Key Facts
- 16.3.2 Business Description
- 16.3.3 Products and Services
- 16.3.4 Financial Overview
- 16.3.5 SWOT Analysis
- 16.3.6 Key Developments
16.4 Virbac SA
- 16.4.1 Key Facts
- 16.4.2 Business Description
- 16.4.3 Products and Services
- 16.4.4 Financial Overview
- 16.4.5 SWOT Analysis
- 16.4.6 Key Developments
16.5 Phibro Animal Health Corp
- 16.5.1 Key Facts
- 16.5.2 Business Description
- 16.5.3 Products and Services
- 16.5.4 Financial Overview
- 16.5.5 SWOT Analysis
- 16.5.6 Key Developments
16.6 HIPRA SA
- 16.6.1 Key Facts
- 16.6.2 Business Description
- 16.6.3 Products and Services
- 16.6.4 Financial Overview
- 16.6.5 SWOT Analysis
- 16.6.6 Key Developments
16.7 Indian Immunologicals Ltd
- 16.7.1 Key Facts
- 16.7.2 Business Description
- 16.7.3 Products and Services
- 16.7.4 Financial Overview
- 16.7.5 SWOT Analysis
- 16.7.6 Key Developments
16.8 Esox Biologics Ltd
- 16.8.1 Key Facts
- 16.8.2 Business Description
- 16.8.3 Products and Services
- 16.8.4 Financial Overview
- 16.8.5 SWOT Analysis
- 16.8.6 Key Developments
16.9 Ceva Polchem Pvt Ltd
- 16.9.1 Key Facts
- 16.9.2 Business Description
- 16.9.3 Products and Services
- 16.9.4 Financial Overview
- 16.9.5 SWOT Analysis
- 16.9.6 Key Developments
16.10 Aquatic Diagnostics Ltd
- 16.10.1 Key Facts
- 16.10.2 Business Description
- 16.10.3 Products and Services
- 16.10.4 Financial Overview
- 16.10.5 SWOT Analysis
- 16.10.6 Key Developments

17. Appendix

17.1 About The Insight Partners